Cashed up to q4202310 Nov 2022 16:53
From 26 August 2022 RNS
“Extension of cash runway
Taking this action means that existing funds, which would otherwise have been fully utilised by April 2023, will now extend to Q4 2023. Pre-clinical work for OCT130401 will continue, ensuring that Programme 2 is Phase I ready in early 2023. Development work for Programmes 3 and 4 will also continue, with the Company still on target to be at pre-clinical stage (for programme 3) and lead stage (for programme 4) with these programmes by Q2 2023.“
Will be adding more tomorrow to my 2m shares bought today with profits from THG
DYOR